Cargando…
Dapsone hypersensitivity syndrome
Autores principales: | Zhao, Qing, Sun, Lele, Sun, Yonghu, Naisbitt, Dean, Liu, Hong, Zhang, Furen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10325760/ https://www.ncbi.nlm.nih.gov/pubmed/37057725 http://dx.doi.org/10.1097/CM9.0000000000002492 |
Ejemplares similares
-
Dapsone‐ and nitroso dapsone‐specific activation of T cells from hypersensitive patients expressing the risk allele HLA‐B*13:01
por: Zhao, Qing, et al.
Publicado: (2019) -
Validation study of HLA-B*13:01 as a biomarker of dapsone hypersensitivity syndrome in leprosy patients in Indonesia
por: Krismawati, Hana, et al.
Publicado: (2020) -
Activation of human CD8+ T-cells with nitroso dapsone-modified HLA-B*13:01-binding peptides()
por: Almutairi, Mubarak, et al.
Publicado: (2023) -
A Review on Dapsone Hypersensitivity Syndrome Among Chinese Patients with an Emphasis on Preventing Adverse Drug Reactions with Genetic Testing
por: Wang, Na, et al.
Publicado: (2017) -
Severe dapsone hypersensitivity syndrome in a child
por: Choi, So Yoon, et al.
Publicado: (2013)